Referred to us by a banker, Enlivex needed help realigning their positioning as a clinical-stage company and effectively conveying their science and technology to potential investors and partners.

Leveraging our expertise in science communication, marketing, and web design, we helped Enlivex redefine their brand and messaging to showcase their clinical-stage advancements. We accomplished this by redesigning their scientific and mechanism of action illustrations, streamlining their investor deck to a fraction of its original length, and crafting a concise and compelling narrative that clearly explained their innovative platform. This new story was translated into a new website, developed and designed from the ground up to become an extension of their corporate deck and provide cohesive messaging and branding across marketing channels.